Resources

This document details the benefits of antiretroviral therapy as HIV prevention, including the importance of HIV testing, linkage to and retention in medical care for persons diagnosed with HIV, and adherence to prescribed HIV treatment regimens.  It puts treatment as prevention in perspective and looks at challenges and the future of HIV prevention.  The document also details how CDC funding supports and expands prevention services for persons living with HIV and lists a variety of related references.

The Common Patient Assistance Program (PAP) Application can be used to apply for any pharmaceutical assistance program (PAP) offered by pharmaceutical companies. The application was developed collaboratively by the Department of Health and Human Services, nine pharmaceutical companies, the National Alliance of State and Territorial AIDS Directors, and community stakeholders.

This curriculum focuses on botanicals commonly used by the Hispanic population.  After reviewing this slide set with speaker notes, participants should to be able to: 1) explain the interplay of HIV treatment, botanical remedies and spirituality in Latino patients; 2) describe some benefits and risks of common botanical remedies, and 3) encourage Latino patients to disclose botanical use through effective provider-patient communication techniques.

These slides from a webinar on January 16, 2013 address evidence-based recommendations for improving entry into and retention in care, and improving medication adherence for persons living with HIV infection. Topics include monitoring, successful intervention approaches, and review of practical resources.  There is also a link to the recorded webinar.

This site is a free resource for qualified healthcare providers, where they can create, print, and document personalized treatment plans for their patients in English or Spanish.  It also has a link to a tool designed for patients to create free medication schedules and receive reminders by text or email about taking and refilling medications. 

This presentation by Charles B. Hicks, M.D., is a case-based review of strategies to individualize and optimize HIV management in the primary care setting.  Dr. Hicks looks at current guidelines for when to start antiretroviral therapy (ART), how to assess patients considering ART, and choices for initial ART.  It is also available for CME credit (see trainings).  Registration, which is free, is required to download the slides.
 

These guidelines were revised in March 2012 to include a new antiretroviral drug cost table and a new section on HIV and older patients.  Key updates include: initiation of antiretroviral treatment (ART) in treatment-naive patients, an expanded discussion on the use of hormonal contraception in women living with HIV, new information related to HIV/Hepatitis C coinfection, recent data on pharmacokinetic interactions between drugs commonly prescribed for HIV-infected patients, timing of initiation of ART in patients with HIV who are diagnosed with tuberculosis, and the role of effective ART in preventing HIV transmission.
 

This document reviews information about the number of people in the United States engaged in five stages of HIV care from a comprehensive analysis released by the Centers for Disease Control and Prevention in July 2012 based on HIV prevalence data from 2009 and other data sources.  The document also includes charts showing HIV care by race/ethnicity, age, risk group, and gender.